Transcode Therapeutics, Inc.’s Q3 2026 10-Q window runs Nov 12, 2026 to Nov 17, 2026.
Based on 8 prior 10-Q filings.
Transcode Therapeutics, Inc. · CIK 1829635 · Engraved from SEC EDGAR